| This week's sponsor is Premier Research. | |  | Overcoming Risk in Oncology Drug Development
Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. Built for biotech. |
Today's Rundown Featured Story | | | Friday, June 14, 2019 Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem. |
|
|
Top Stories Friday, June 14, 2019 Global Blood Therapeutics has shared updated data on the sickle cell disease trial it hopes will secure FDA approval of voxelotor. The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo. Friday, June 14, 2019 BerGenBio has posted updated data from its phase 2 trial of bemcentinib in acute myeloid leukaemia (AML). The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy. Monday, June 10, 2019 Read the case study to learn how Covance helped a sponsor who wanted to get all sites for a 2,700 patient study up and running as quickly as possible. Covance leveraged their proprietary historical investigator performance database to see which investigators outperformed their peers on a consistent basis and had the capacity to run multiple studies at the same time. Friday, June 14, 2019 After its nearly $2 billion buyout by oncology giant Roche last winter, Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data. Thursday, June 13, 2019 In this week's EuroBiotech Report, J&J bags option on Darzalex successor, Sobi overhauls R&D group and ReViral hires CEO. Friday, June 14, 2019 The couple behind China's Hansoh and Hengrui is among the biopharma industry's richest; Korean prosecutors grilled a top Samsung executive over accounting case; another Aurobindo plant is cited by the FDA; and more. Friday, June 14, 2019 Novartis says hello to new pharma chief Marie-France Tschudin as Paul Hudson jumps to Sanofi following Olivier Brandicourt's retirement; Amid BMS' R&D shuffle, F-star nabs immuno-oncology exec and Grail finds a new CEO in former Juno chief. Those moves plus more hirings, firings and retirings throughout the industry. | This week's sponsor is Cobra Biologics. | |  |
Cobra provides expert scale up and manufacturing of customers’ live biotherapeutic microbiota products, manufacturing to cGMP standards for clinical and commercial scale. We also offer DNA and viral vector services, with experienced project teams nurturing customers’ products within GMP approved facilities. Visit our website to find out more. |
Resources Sponsored by: OCT Clinical Trials | June 20, 2019 | 2pm EDT / 11am PDT Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia. Sponsored by: AlphaSense What is agile competitive intelligence, and how can it help take market research to the next level? Sponsored by: Reprints Desk, Inc. Get 5 quick tips for faster research and better results! Sponsored by: Blue Latitude Health In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report. Sponsored by: Patheon, by Thermo Fisher Scientific Increase Safety & Flexibility with Flow Chemistry Sponsored by: Veeva IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now. Sponsored by: WCG Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. | 
